您好,欢迎来到易推广 请登录 免费注册

上海陶术生物科技有限公司 主营产品:生物试剂,实验服务等

当前位置:易推广 > 上海陶术生物科技有限公司 > 产品展示

企业档案

会员类型:会员

已获得易推广信誉   等级评定
139成长值

(0 -40)基础信誉积累,可浏览访问

(41-90)良好信誉积累,可接洽商谈

(91+  )优质信誉积累,可持续信赖

易推广会员:5

工商认证 【已认证】

最后认证时间:

注册号: 【已认证】

法人代表: 【已认证】

企业类型:生产商 【已认证】

注册资金:人民币万 【已认证】

产品数:86101

参观次数:3492151

手机网站:http://m.yituig.com/c135739/

旗舰版地址:http://tsbiochem.app17.com

自主品牌

已选条件

  • T80621Semzuvolimab;化合物 SemzuvolimabUB421;UB421

    Semzuvolimab, a murine IgG1κ antibody, targets the p55 T-cell surface antigen T4/Leu-3 (CD4). It has demonstrated capabilities to neutralize HIV infection and may inhibit HIV in patients on stable highly active antiretroviral therapy (HAART) [1] [2].

    价 格:¥电议型 号:T80621产 地:中国大陆

  • T80619Rosnilimab;化合物 RosnilimabANB030;ANB030

    Rosnilimab is a humanized IgG1-κ antibody that targets PD-1 [1] [2].

    价 格:¥电议型 号:T80619产 地:中国大陆

  • T80617Reozalimab;化合物 ReozalimabReozalimab

    Rezilimab is a bispecific antibody that targets PD-1/PD-L1 and mediates antibody-dependent cell cytotoxicity (ADCC) in cancer research [1] [2].

    价 格:¥电议型 号:T80617产 地:中国大陆

  • T80616Posdinemab;化合物 PosdinemabPosdinemab

    Posdinemab, a humanized IgG1κ antibody, targets the microtubule-associated protein tau (MAPT) [1].

    价 格:¥电议型 号:T80616产 地:中国大陆

  • T80615Enoticumab;化合物 EnoticumabREGN421;REGN421

    Enoticumab (REGN421, SAR153192) is an IgG1κ antibody that specifically targets human Delta-like ligand 4 (Dll4), which serves as a crucial component of the Notch signaling pathway and regulates the uptake of fatty acids through non-transcriptional modulation of macropinocytosis-dependent long-chain fatty acid absorption. Demonstrated efficacy in vivo, Enoticumab was shown to inhibit tumor growth by 86% and 83% in subcutaneous TOV-112D and intraperitoneal A2780 human ovarian tumor xenograft mouse

    价 格:¥电议型 号:T80615产 地:中国大陆

  • T80614Serclutamab;化合物 SerclutamabDC-1630423|||PR-1594407;DC-1630423|||PR-1594407

    Serclutamab, a humanized chimeric monoclonal antibody of the IgG1-κ isotype, selectively targets the epidermal growth factor receptor (EGFR). It is primarily produced in Chinese Hamster Ovary (CHO) cells [1].

    价 格:¥电议型 号:T80614产 地:中国大陆

  • T80613Linvoseltamab;化合物 LinvoseltamabREGN5458;REGN5458

    Linvoseltamab, a bispecific antibody, targets both BCMA (TNFRSF17) and CD3 epsilon, demonstrating a favorable safety profile and promising efficacy in relapsed/refractory multiple myeloma (RRMM) [1][2].

    价 格:¥电议型 号:T80613产 地:中国大陆

  • T80612Pimurutamab;化合物 PimurutamabPimurutamab

    Pimurutamab, a humanized IgG1-κ antibody, selectively targets the epidermal growth factor receptor (EGFR) and is primarily produced by CHO-K1 cells [1].

    价 格:¥电议型 号:T80612产 地:中国大陆

  • T80611Sasanlimab;化合物 SasanlimabPF-06801591;PF-06801591

    Sasanlimab (PF-06801591), a humanized IgG4-κ antibody, selectively targets PD-1 and is primarily produced in Chinese Hamster Ovary (CHO) cells [1].

    价 格:¥电议型 号:T80611产 地:中国大陆

  • T80610Romilkimab;化合物 RomilkimabSAR156597;SAR156597

    Romilkimab (SAR156597) is a chimeric humanized immunoglobulin (Ig) antibody designed to specifically target interleukins 4 and 13 (IL-4 and IL-13) [1].

    价 格:¥电议型 号:T80610产 地:中国大陆

  • T80609Mecbotamab;化合物 MecbotamabMecbotamab

    Mecbotamab vedotin (BA3011) is a humanized IgG1-κ antibody engineered to target the AXL receptor tyrosine kinase (AXL). Serving as a conditionally active biologic (CAB), mecbotamab is conjugated to monomethyl auristatin E (MMAE) through a cleavable linker, creating an antibody-drug conjugate (ADC) for therapeutic use [1] [2].

    价 格:¥电议型 号:T80609产 地:中国大陆

  • T80608Ebronucimab;化合物 EbronucimabAK102;AK102

    Ebronucimab (AK102), an IgG1-λ2 antibody, specifically targets PCSK9 and is predominantly produced in CHO DG44 (Chinese Hamster Ovary) cells [1].

    价 格:¥电议型 号:T80608产 地:中国大陆

  • T80607Eblasakimab;化合物 EblasakimabCSL-334|||ASLAN004;CSL-334|||ASLAN004

    Eblasakimab (also known as ASLAN004 or CSL-334) is a human IgG4 monoclonal antibody that selectively binds to IL13RA1, and is predominantly produced in CHO-K1 cells [1].

    价 格:¥电议型 号:T80607产 地:中国大陆

  • T80606Duvortuxizumab;化合物 DuvortuxizumabMGD 011;MGD 011

    Duvortuxizumab (MGD 011) is a chimeric, humanized immunoglobulin (IG) antibody that specifically targets CD19 and CD3E receptors [1].

    价 格:¥电议型 号:T80606产 地:中国大陆

  • T80605Dusigitumab;化合物 DusigitumabMEDI 573;MEDI 573

    Dusigitumab (MEDI 573) is a human IgG2λ monoclonal antibody targeting the insulin-like growth factors IGF2 and IGF1, offering therapeutic potential for conditions related to these proteins [1].

    价 格:¥电议型 号:T80605产 地:中国大陆

  • T80604Duligotuzumab;化合物 DuligotuzumabRG 7597|||MEHD-7945A;RG 7597|||MEHD-7945A

    Duligotuzumab (MEHD-7945A; RG 7597) is a humanized IgG-κ monoclonal antibody targeting Her3 (ErbB3) [1].

    价 格:¥电议型 号:T80604产 地:中国大陆

  • T80603Dresbuxelimab;化合物 DresbuxelimabAK-119;AK-119

    Dresbuxelimab (AK-119), an IgG-κ monoclonal antibody, selectively targets CD73 and is commonly produced using a Chinese Hamster Ovary (CHO) cell expression system [1].

    价 格:¥电议型 号:T80603产 地:中国大陆

  • T80602Dovanvetmab;化合物 DovanvetmabZTS-00521505;ZTS-00521505

    Dovanvetmab (ZTS-00521505) is an IgG1-κ monoclonal antibody that targets feline interleukin 31 (Felcat IL31), primarily produced in Chinese Hamster Ovary (CHO) cells [1].

    价 格:¥电议型 号:T80602产 地:中国大陆

  • T80599Dectrekumab;德屈库单抗QAX576;QAX576

    Dectrekumab (QAX576), a humanized monoclonal antibody targeting IL-13, significantly reduces intraepithelial esophageal eosinophil counts and normalizes dysregulated esophageal disease-related transcripts in Eosinophilic esophagitis (EoE), offering sustained benefits. It is valuable for inflammation and immunology research [1].

    价 格:¥电议型 号:T80599产 地:中国大陆

  • T80597Dafsolimab;化合物 DafsolimabSPV-T3a;SPV-T3a

    Dafsolimab (SPV-T3a), an IgG2a murine monoclonal antibody (anti-CD3), induces cell death by modulating and activating the CD3/T cell receptor complex and is utilized in research pertaining to graft-versus-host disease (GVHD) [1].

    价 格:¥电议型 号:T80597产 地:中国大陆

快速导航

在线咨询

提交